Skip to content

Medical emergency? What to do

New approach flushes out hidden HIV

3-RXPublished August 12, 20053 min read

Key points

  • A strategy used by the wily AIDS virus to perpetuate infection may be susceptible to attack, according to a new report.
  • This week, researchers report a way to flush the latent virus out of its hiding place in resting CD4 cells (immune cells that have not been activated to fight off microbes), and then pick it off with potent drugs.
  • Margolis, from the University of Texas Southwestern Medical Center at Dallas, and his associates report their results in this week's Lancet medical journal.
  • For their current study, Margolis and his colleagues worked with four HIV-infected volunteers who were taking HAART and had very low viral levels for more than 2 years.

A strategy used by the wily AIDS virus to perpetuate infection may be susceptible to attack, according to a new report.

One of the fundamental difficulties in trying to eradicate HIV in people infected with the virus is that, even with the best antiviral treatment, small numbers of the virus can lie dormant in immune cells, ready to break out and multiply rapidly when the opportunity occurs.

This week, researchers report a way to flush the latent virus out of its hiding place in resting CD4 cells (immune cells that have not been activated to fight off microbes), and then pick it off with potent drugs.

The weapon that exposes the hidden virus is a drug that's commonly used to treat bipolar disorder -- valproic acid. According to results of a proof-of-concept study, treatment of HIV-infected patients with valproic acid, along with intensified 'HAART' (highly active antiretroviral therapy) seems to accelerate clearance of replication-competent HIV.

Dr. David M. Margolis, from the University of Texas Southwestern Medical Center at Dallas, and his associates report their results in this week's Lancet medical journal.

The researchers noted that valproic acid inhibits an enzyme called HDAC1, which is responsible for enabling HIV to remain latent inside cells. "We know that in model systems in the laboratory, isolating resting cells from patients and incubating them with valproic acid induces expression of virus," Margolis explained in an interview with Reuters Health.

For their current study, Margolis and his colleagues worked with four HIV-infected volunteers who were taking HAART and had very low viral levels for more than 2 years. The researchers intensified HAART treatment by adding the relatively new fusion inhibitor enfuvirtide (a.k.a., T-20), and then had the subjects take valproic acid, 500 to 750 milligrams twice daily, for 3 months.

"We then found a significant decrease in the amount of recoverable virus and the amount of cells that could express replication-competent virus," Margolis said. Specifically, the frequency of infection in resting CD4 cells declined in all four patients, and to a significant extent in three of them..

He added, however, that this short-term treatment did not result in cure for any of the subjects, and that further research will be required to confirm these results and to test the efficacy of longer-term HDAC1 inhibition.

"These results, though preliminary, merit further urgent study," Dr. Jean-Pierre Routy, from McGill University Health Centre in Montreal, asserts in a related editorial.

"This is the first glimpse of a new therapeutic approach that might represent a possible step towards making HIV-infection no longer a chronic disease," he writes

SOURCE: Lancet, August 13, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underAIDS/HIV

Keep reading

AIDS/HIV

Economic crisis could worsen HIV/AIDS epidemic: UN

Economic crisis and climate change concerns could affect the fight against the AIDS virus and lead to a "universal nightmare", the head of the United Nations' agency for HIV/AIDS said on Sunday. The global economic…

2 min read

AIDS/HIV

Possible cure for HIV patients?

On December 7th, an article was published in PLoS One that explained that researchers from UCLA AIDS Institute have found a way to use human stem cells to fight HIV-infected cells. The human stem cells can be…

1 min read

AIDS/HIV

HIV-infected Chinese children struggle with stigma

The second storey of this nondescript building in Fuyang city in China's central province of Anhui houses HIV-positive orphans, but unlike many other similar establishments, there are no signboards outside. Heavy…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.